Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Kodiak Sciences Inc. on June 2, 2025. The filing details the outcomes of three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Proxies representing 43,370,916 shares (82.20% of total shares entitled to vote) were present and voted. The results for the proposals were as follows:
- Proposal One (Election of Class I Directors):
- Richard S. Levy, M.D.: Elected with 29,171,558 votes For, 8,444,575 Withheld, and 5,754,783 Broker Non-Votes.
- Robert A. Profusek, J.D.: Elected with 24,691,172 votes For, 12,924,961 Withheld, and 5,754,783 Broker Non-Votes.
- Proposal Two (Advisory Approval of Executive Compensation): Approved with 35,200,864 votes For, 2,365,796 Against, and 49,473 Abstentions.
- Proposal Three (Ratification of Auditors): Ratified the appointment of PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2025, with 43,031,110 votes For, 36,185 Against, and 303,621 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 22, 2025, for detailed background on the director nominees and executive compensation.
- Confirm the tenure of the newly elected Class I directors, which extends until the 2028 annual meeting.
- Note the significant number of broker non-votes (5,754,783) recorded for the director election and executive compensation proposals.